What is CURX's current stock price?

CURX (Curanex Pharmaceuticals Inc Common Stock) is currently trading at $0.33 with a market cap of $9.4M.

What sector is Curanex Pharmaceuticals Inc Common Stock in?

Curanex Pharmaceuticals Inc Common Stock (CURX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

CURX Curanex Pharmaceuticals Inc Common Stock

Healthcare

$0.33+1.07%ClosedMarket Cap: $9.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.16

P/S

0.00

EV/EBITDA

-0.78

DCF Value

$0.18

FCF Yield

-120.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-85.4%

ROA

-86.0%

ROIC

-86.8%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-3.2M	$—
Q4 null	$0.00	$-3.1M	$—
FY null	$0.00	$-4.2M	$—
Q3 null	$0.00	$-954.1K	$—

Trading Activity

Insider Trades

View All

Zhong Huijuandirector, officer: Chief Science Officer

SellTue Sep 02

Yan Yongdirector:

SellTue Sep 02

Xie Liqinofficer

SellTue Sep 02

Liu Jundirector, 10 percent owner, officer: CEO and President

SellTue Sep 02

Hsu Helen Hongdirector:

SellTue Sep 02

Latest News

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND SubmissionGlobeNewsWire · Mon Mar 30

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-3.22

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. The company was founded in 1996 and is headquartered in Jericho, New York.

Peers